DEPARTMENT PROFILE

ALTIUS

Life Sciences

1 ranked lawyersBand 3BelgiumEurope 2021 View ranking table
chambers review
department information
Ranked Lawyers
chambers review
department information
Ranked Lawyers

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Acts on a broad range of EU regulatory matters, with a particular focus on regulations concerning plant protection and food additives. Advises pharmaceutical and agrochemical companies on market access, clinical trials and restrictions around the export of medical equipment. Also assists with medical procurement matters. Collaborates with the firm's market-leading intellectual property team to represent pharmaceutical companies in contentious patent proceedings.

Strengths

A client notes that the team "works in a thorough manner and within tight deadlines."

Work highlights

Advised SESVanderHave on annulment proceedings concerning the use of neonicotinoids under the EU Plant Protection Products Regulation.

Notable practitioners

Christophe Ronse advises clients on market access, clinical trials and medical equipment matters, including tendering. A client appreciates that Ronse "goes the extra mile to provide the best possible and most pragmatic legal advice." Pharmaceutical clients also benefit from his strong intellectual property practice.

Department Information

This content is provided by ALTIUS.

Overview

Life Sciences

Our Life Sciences group has a proven track record advising clients on contentious and non-contentious matters in the life sciences and healthcare industry. Our team works on cases that continue to define the landscape for pharmaceutical patents in Belgium in particular.

Led by IP and Litigation Partner Christophe Ronse, the team represents several (multi)national pharmaceutical, medical and biotech companies on the legal issues they encounter during the various stages of their development. The team further includes Philippe de Jong, IP partner who has particular expertise in the protection of plant biotechnological inventions, Tom Vantroyen, partner at the Corporate department, William Timmermans, head of the Regulatory department, as well as several senior and junior associates.

Nagoya protocol-related work

ALTIUS has unmatched experience in cross-border Nagoya Protocol compliance matters, concerning the use of natural biological resources for R&D purposes. Philippe de Jong has advised numerous international clients such on this topic.

Agri-food

Our Agri-food law practice is also increasingly called upon for its niche expertise. This innovative practice, led by Philippe de Jong, has a proven track record advising clients in contentious and non-contentious matters in the green biotech industry as well as in the broader life sciences industry, both in respect of intellectual property and regulatory issues.

Members

de Jong, Philippe

Ronse, Christophe

Timmermans, William

Vantroyen, Tom

Clients

Bayer Pharma

Breeders Trust

Genentech

Gilead

ICOS Corporation

MITSUI Global Investment

MSD

Novartis

Pixley Berries

SES Vanderhave NV

Industries

Chemicals

Consumer Product Manufacturing

Food & Drink Producers

Health Care

Pharmaceuticals & Life Sciences

Software & Computer Services

Life Sciences Department

ALTIUS

firm
Department location

Tour & Taxis Building, Havenlaan 86C

Box 414

Avenue du Port

Brussels

Brussels Capital Region

Belgium

1000

View Firm Profile

Ranked Lawyers

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

Belgium

Life Sciences: EU


Christophe Ronse
Band 2